Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2 is a key anti-apoptotic protein that regulates programmed cell death by controlling mitochondrial membrane permeability. It acts primarily as an inhibitor of apoptosis, promoting cell survival. Overexpression of BCL2 is frequently observed in various cancers, conferring resistance to apoptotic signals, making it a critical target in oncology research. BCL2 protein localizes mainly to the outer mitochondrial membrane, endoplasmic reticulum membrane, and nuclear envelope/membrane.
Inhibition of BCL2, promoting apoptosis in cancer cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis regulator BCL2.